The ASX has been trading flat at around 7,864 points.
Financials has been the best performing sector, up 0.3%, followed by Materials, up 0.15% and Energy, up 0.1%.
Utilities has been the worst performer, down 1.1%, followed by Industrials and Staples, both down 0.55%.
Opthea (ASX:OPT) has been the most watched on HotCopper forums today. The company is in a voluntary suspension pending the release of top line results of its COAST clinical trial.
Also trending Imugene (ASX:IMU) has revealed the US Food and Drug Administration has granted Fast Track Designation to its allogeneic CAR T-cell therapy, azer-cel (azercabtagene zapreleucel), for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Rounding out the most discussed is Arizona Lithium (ASX:AZL) after kicking off a share purchase plan to raise $2 million to advance the Prairie project.
You’re up to date, see you later for market close.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。